Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2022 Diabetes Care 1,623 citations

Abstract

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional health care team providing diabetes care in the U.S. and Europe. A systematic examination of publications since 2018 informed new recommendations. These include additional focus on social determinants of health, the health care system, and physical activity behaviors, including sleep. There is a greater emphasis on weight management as part of the holistic approach to diabetes management. The results of cardiovascular and kidney outcomes trials involving sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease. After a summary listing of consensus recommendations, practical tips for implementation are provided.

Keywords

MedicineDiabetes mellitusType 2 diabetesInternal medicineEndocrinologyAssociation (psychology)

MeSH Terms

AdultHumansUnited StatesDiabetes MellitusType 2Hypoglycemic AgentsHyperglycemiaConsensusEuropeGlucagon-Like Peptide-1 Receptor

Affiliated Institutions

Related Publications

Publication Info

Year
2022
Type
review
Volume
45
Issue
11
Pages
2753-2786
Citations
1623
Access
Closed

Citation Metrics

1623
OpenAlex
87
Influential
1255
CrossRef

Cite This

Melanie J. Davies, Vanita R. Aroda, Billy S. Collins et al. (2022). Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care , 45 (11) , 2753-2786. https://doi.org/10.2337/dci22-0034

Identifiers

DOI
10.2337/dci22-0034
PMID
36148880
PMCID
PMC10008140

Data Quality

Data completeness: 90%